On July 17, at the 2026 World Artificial Intelligence Conference and High-Level Meeting on Global AI Governance, Baichuan Intelligence unveiled for the first time the real-world results of Baichuan-M4 in specialized medical fields like oncology and pediatrics. The oncology-specific AI, jointly developed with the National Cancer Center and the Cancer Hospital of the Chinese Academy of Medical Sciences, as well as the AI pediatrician created in partnership with the National Center for Children’s Health and Beijing Children’s Hospital, are now undergoing validation in actual clinical settings.